Cariprazine hydrochloride

Vraylar, Reagila (cariprazine hydrochloride) is a small molecule pharmaceutical. Cariprazine hydrochloride was first approved as Vraylar on 2017-07-13. It is used to treat in the USA. It has been approved in Europe to treat schizopyrenida. Vraylar's patents are valid until 2029-09-17 (FDA).